Skip to main content
. 2021 Aug 4;4(8):e2119084. doi: 10.1001/jamanetworkopen.2021.19084

Table 2. Participant Characteristics.

Characteristic Participants, No (%)
European ancestry, (n = 33 594) African ancestry, (n = 3801) Latinx ancestry, (n = 2196)
Age, mean (SD), ya 66.1 (17.7) 59.6 (16.5) 59.9 (19.4)
Breast cancer diagnosis 3960 (11.8) 274 (7.2) 147 (6.7)
Age at breast cancer diagnosis, mean (SD), yb 60.7 (13.0) 58.8 (12.5) 60.1 (13.0)
Estrogen receptor status, No. (% of cases)
Positive 1052 (26.6) 20 (7.3) 22 (15.0)
Negative 241 (6.1) 15 (5.5) 4 (2.7)
Missing 2667 (67.3) 239 (87.2) 121 (82.3)
eMERGE network site
Columbia University Medical Center 202 (0.6) 73 (1.9) 158 (7.2)
Geisinger 1330 (4) 4 (0.1) 8 (0.4)
Partners Healthcare 13 392 (39.9) 927 (24.4) 1093 (49.8)
Kaiser Permanente Washington Health Research Institute/University of Washington 1646 (4.9) 65 (1.7) 55 (2.5)
Mayo Clinic 3547 (10.6) 10 (0.3) 22 (1)
Marshfield Clinic Research Foundation 2815 (8.4) 8 (0.4)
Mount Sinaic 220 (0.7) 2515 (66.2) 742 (33.8)
Northwestern University 1878 (5.6) 207 (5.4) 23 (1)
Vanderbilt University 8564 (25.5) 0 87 (4)

Abbreviation: eMERGE, Electronic Medical Records and Genomics.

a

Age was calculated at the time of electronic phenotyping algorithm deployment.

b

Age at breast cancer diagnosis was defined as the age at the first breast cancer International Classification of Diseases–related code.

c

Mount Sinai only executed the phenotype algorithm for case-control definition; no estrogen receptor status data were extracted for this site.